Studies on the interaction between growth hormone and dihydroergotamine in adipose cells. II. Augmentation of the lipolytic response.
D000273:Adipose Tissue / Q000166:cytology / Q000378:metabolism*; D000818:Animals; D002417:Cattle; D002477:Cells / Q000378:metabolism; D003907:Dexamethasone / Q000037:antagonists & inhibitors / Q000494:pharmacology; D004357:Drug Synergism; D004822:Epididymis / Q000166:cytology / Q000378:metabolism; D004878:Ergotamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000096:biosynthesis; D005990:Glycerol / Q000096:biosynthesis; D013006:Growth Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010928:Placental Lactogen / Q000494:pharmacology; D011388:Prolactin / Q000494:pharmacology; D011691:Puromycin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains
D005230:Fatty Acids, Nonesterified; D011691:Puromycin; D003907:Dexamethasone; D011388:Prolactin; D013006:Growth Hormone; D010928:Placental Lactogen; D005990:Glycerol; D004878:Ergotamine